Australia, July 22 -- Syncromune Inc., owns the trademark (2454294) for 'ACCULYSE' till March 18, 2034.
Status: protected:
Registered/protected
Class: 10 [Medical devices for the treatment of solid tumor cancers which deliver direct injections of drugs into the tumor or to a localized region of the body causing tumor cell lysis; medical apparatus, namely, infusion and injection devices for locally targeted drug administration.]
Type of Mark: Word
Date of Acceptance: May 14
Registration Advertised: July 21
For further details contact Mallesons and Jessica L. Rothstein Goodwin Procter LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2454294.
Disclaimer: Curated by HT Syndication.
